These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 22648771)

  • 41. Non-viral ocular gene therapy: potential ocular therapeutic avenues.
    Bloquel C; Bourges JL; Touchard E; Berdugo M; BenEzra D; Behar-Cohen F
    Adv Drug Deliv Rev; 2006 Nov; 58(11):1224-42. PubMed ID: 17095114
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gene transfer systems derived from Visna virus: analysis of virus production and infectivity.
    Berkowitz RD; Ilves H; Plavec I; Veres G
    Virology; 2001 Jan; 279(1):116-29. PubMed ID: 11145895
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Biodegradable polymers as non-viral carriers for plasmid DNA delivery.
    Luten J; van Nostrum CF; De Smedt SC; Hennink WE
    J Control Release; 2008 Mar; 126(2):97-110. PubMed ID: 18201788
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Non-viral gene therapy approach for regenerative recovery of skin wounds in mammals].
    Efremov AM; Dukhovlinov IV; Dizhe EB; Burov SV; Leko MV; Akif'ev BN; Mogilenko DA; Ivanov IA; Perevozchikov AP; Orlov SV
    Tsitologiia; 2010; 52(5):371-9. PubMed ID: 20586271
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Modular protein engineering for non-viral gene therapy.
    Arís A; Villaverde A
    Trends Biotechnol; 2004 Jul; 22(7):371-7. PubMed ID: 15245910
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Animal models for prenatal gene therapy: the nonhuman primate model.
    Mattar CN; Biswas A; Choolani M; Chan JK
    Methods Mol Biol; 2012; 891():249-71. PubMed ID: 22648776
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Vector systems for prenatal gene therapy: principles of adeno-associated virus vector design and production.
    Binny CJ; Nathwani AC
    Methods Mol Biol; 2012; 891():109-31. PubMed ID: 22648770
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Candidate diseases for prenatal gene therapy.
    David AL; Waddington SN
    Methods Mol Biol; 2012; 891():9-39. PubMed ID: 22648766
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Construction and characterization of an in-vivo linear covalently closed DNA vector production system.
    Nafissi N; Slavcev R
    Microb Cell Fact; 2012 Dec; 11():154. PubMed ID: 23216697
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of DNA vector topology on non-viral gene therapeutic safety and efficacy.
    Sum CH; Wettig S; Slavcev RA
    Curr Gene Ther; 2014; 14(4):309-29. PubMed ID: 25039613
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Animal models for prenatal gene therapy: choosing the right model.
    Mehta V; Peebles D; David AL
    Methods Mol Biol; 2012; 891():183-200. PubMed ID: 22648773
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nanoparticle-mediated gene delivery: state of the art.
    Ravi Kumar M; Hellermann G; Lockey RF; Mohapatra SS
    Expert Opin Biol Ther; 2004 Aug; 4(8):1213-24. PubMed ID: 15268657
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Minicircle DNA vectors for gene therapy: advances and applications.
    Gaspar V; de Melo-Diogo D; Costa E; Moreira A; Queiroz J; Pichon C; Correia I; Sousa F
    Expert Opin Biol Ther; 2015 Mar; 15(3):353-79. PubMed ID: 25539147
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Production of non viral DNA vectors.
    Schleef M; Blaesen M; Schmeer M; Baier R; Marie C; Dickson G; Scherman D
    Curr Gene Ther; 2010 Dec; 10(6):487-507. PubMed ID: 21054244
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficient production of superior dumbbell-shaped DNA minimal vectors for small hairpin RNA expression.
    Yu H; Jiang X; Tan KT; Hang L; Patzel V
    Nucleic Acids Res; 2015 Oct; 43(18):e120. PubMed ID: 26068470
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Rational vector design for efficient non-viral gene delivery: challenges facing the use of plasmid DNA.
    Mairhofer J; Grabherr R
    Mol Biotechnol; 2008 Jun; 39(2):97-104. PubMed ID: 18327557
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Animal models for prenatal gene therapy: rodent models for prenatal gene therapy.
    Roybal JL; Endo M; Buckley SM; Herbert BR; Waddington SN; Flake AW
    Methods Mol Biol; 2012; 891():201-18. PubMed ID: 22648774
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Principles of safety, efficacy and stability in gene therapy--review.
    Hu CS; Hong JY; Douglas WL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Jun; 12(3):392-6. PubMed ID: 15228676
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gene delivery systems: Bridging the gap between recombinant viruses and artificial vectors.
    Navarro J; Oudrhiri N; Fabrega S; Lehn P
    Adv Drug Deliv Rev; 1998 Mar; 30(1-3):5-11. PubMed ID: 10837597
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Controlled release of gene therapy constructs from solid scaffolds for therapeutic applications in orthopedics.
    Venkatesan JK; Falentin-Daudré C; Leroux A; Migonney V; Cucchiarini M
    Discov Med; 2018 Apr; 25(138):195-203. PubMed ID: 29723490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.